贝瑞基因：全资子公司基因测序仪NovaSeq™6000Dx-CN-BG获得医疗器械注册证

Core Viewpoint - Berry Genomics' subsidiary has received a medical device registration certificate for its NovaSeq™6000Dx-CN-BG gene sequencer, indicating a significant advancement in the company's product offerings in the field of DNA sequencing [1]. Company Summary - Berry Genomics announced that its wholly-owned subsidiary, Hangzhou Berry Genomics Technology Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration for the NovaSeq™6000Dx-CN-BG gene sequencer [1]. - The NovaSeq™6000Dx-CN-BG utilizes reversible terminator sequencing technology, which is clinically applied for human deoxyribonucleic acid (DNA) sequencing [1].